Global Carcinoid Syndrome Diarrhea Treatment Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 29261
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 90
  • list Pharmaceuticals and Healthcare

Carcinoid syndrome is a group of symptoms that can occur in patients suffering from carcinoid tumors which also called as metastatic neuroendocrine tumors. Carcinoid tumors are rare and these are slow growing tumors. Most of the tumors occur in gastrointestinal tract. According to FDA, carcinoid syndrome occurs in less than 10 percent of people suffering from carcinoid tumors, mostly after the tumor has spread to the liver. This syndrome causes overproduction of serotonin hormone which results in chronic diarrhea. Chronic diarrhea leads to malnutrition, weight loss, electrolyte imbalance and dehydration.

Carcinoid syndrome diarrhea is a rare condition. Treatment available for this condition are expected to get orphan drug status. Government and regulatory body support for development of orphan drug and incentives are expected to drive carcinoid syndrome treatment market. Government allow companies to set high price for the orphan drug and which in turn will generate high revenue. Ineffectiveness of diarrhea controlling agents in case of carcinoid syndromes diarrhea will also drive the growth of this market.

In 2020, the global Carcinoid Syndrome Diarrhea Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Carcinoid Syndrome Diarrhea Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Carcinoid Syndrome Diarrhea Treatment development in United States, Europe and China.

The key players covered in this study

Lexicon Pharmaceuticals

Novartis International

Pharmascience

Omega Laboratories

Teva Pharmaceutical Industries

Mylan

Ipsen

Sirtex Medical

BTG International

Market segment by Type, the product can be split into

Chemotherapy

Somatostatin Analog (SSA) Therapy

Oral Therapy

Market segment by Application, split into

Hospitals

Clinics

Cancer Research Institutes

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Carcinoid Syndrome Diarrhea Treatment status, future forecast, growth opportunity, key market and key players.

To present the Carcinoid Syndrome Diarrhea Treatment development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Carcinoid Syndrome Diarrhea Treatment are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Carcinoid Syndrome Diarrhea Treatment Market Size Growth Rate by Type (2015-2026)

1.4.2 Chemotherapy

1.4.3 Somatostatin Analog (SSA) Therapy

1.4.4 Oral Therapy

1.5 Market by Application

1.5.1 Global Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2015-2026)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Cancer Research Institutes

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Carcinoid Syndrome Diarrhea Treatment Market Size

2.2 Carcinoid Syndrome Diarrhea Treatment Growth Trends by Regions

2.2.1 Carcinoid Syndrome Diarrhea Treatment Market Size by Regions (2015-2026)

2.2.2 Carcinoid Syndrome Diarrhea Treatment Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Carcinoid Syndrome Diarrhea Treatment Market Size by Manufacturers

3.1.1 Global Carcinoid Syndrome Diarrhea Treatment Revenue by Manufacturers (2015-2020)

3.1.2 Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Carcinoid Syndrome Diarrhea Treatment Market Concentration Ratio (CR5 and HHI)

3.2 Carcinoid Syndrome Diarrhea Treatment Key Players Head office and Area Served

3.3 Key Players Carcinoid Syndrome Diarrhea Treatment Product/Solution/Service

3.4 Date of Enter into Carcinoid Syndrome Diarrhea Treatment Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020)

4.2 Global Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)

5 United States

5.1 United States Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)

5.2 Carcinoid Syndrome Diarrhea Treatment Key Players in United States

5.3 United States Carcinoid Syndrome Diarrhea Treatment Market Size by Type

5.4 United States Carcinoid Syndrome Diarrhea Treatment Market Size by Application

6 Europe

6.1 Europe Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)

6.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Europe

6.3 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type

6.4 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application

7 China

7.1 China Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)

7.2 Carcinoid Syndrome Diarrhea Treatment Key Players in China

7.3 China Carcinoid Syndrome Diarrhea Treatment Market Size by Type

7.4 China Carcinoid Syndrome Diarrhea Treatment Market Size by Application

8 Japan

8.1 Japan Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)

8.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Japan

8.3 Japan Carcinoid Syndrome Diarrhea Treatment Market Size by Type

8.4 Japan Carcinoid Syndrome Diarrhea Treatment Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)

9.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Southeast Asia

9.3 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size by Type

9.4 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size by Application

10 India

10.1 India Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)

10.2 Carcinoid Syndrome Diarrhea Treatment Key Players in India

10.3 India Carcinoid Syndrome Diarrhea Treatment Market Size by Type

10.4 India Carcinoid Syndrome Diarrhea Treatment Market Size by Application

11 Central & South America

11.1 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)

11.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Central & South America

11.3 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size by Type

11.4 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size by Application

12 International Players Profiles

12.1 Lexicon Pharmaceuticals

12.1.1 Lexicon Pharmaceuticals Company Details

12.1.2 Company Description and Business Overview

12.1.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.1.4 Lexicon Pharmaceuticals Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.1.5 Lexicon Pharmaceuticals Recent Development

12.2 Novartis International

12.2.1 Novartis International Company Details

12.2.2 Company Description and Business Overview

12.2.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.2.4 Novartis International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.2.5 Novartis International Recent Development

12.3 Pharmascience

12.3.1 Pharmascience Company Details

12.3.2 Company Description and Business Overview

12.3.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.3.4 Pharmascience Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.3.5 Pharmascience Recent Development

12.4 Omega Laboratories

12.4.1 Omega Laboratories Company Details

12.4.2 Company Description and Business Overview

12.4.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.4.4 Omega Laboratories Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.4.5 Omega Laboratories Recent Development

12.5 Teva Pharmaceutical Industries

12.5.1 Teva Pharmaceutical Industries Company Details

12.5.2 Company Description and Business Overview

12.5.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.5.4 Teva Pharmaceutical Industries Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.5.5 Teva Pharmaceutical Industries Recent Development

12.6 Mylan

12.6.1 Mylan Company Details

12.6.2 Company Description and Business Overview

12.6.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.6.4 Mylan Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.6.5 Mylan Recent Development

12.7 Ipsen

12.7.1 Ipsen Company Details

12.7.2 Company Description and Business Overview

12.7.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.7.4 Ipsen Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.7.5 Ipsen Recent Development

12.8 Sirtex Medical

12.8.1 Sirtex Medical Company Details

12.8.2 Company Description and Business Overview

12.8.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.8.4 Sirtex Medical Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.8.5 Sirtex Medical Recent Development

12.9 BTG International

12.9.1 BTG International Company Details

12.9.2 Company Description and Business Overview

12.9.3 Carcinoid Syndrome Diarrhea Treatment Introduction

12.9.4 BTG International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)

12.9.5 BTG International Recent Development

13 Market Forecast 2020-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2020-2026)

13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Carcinoid Syndrome Diarrhea Treatment Key Market Segments

Table Key Players Carcinoid Syndrome Diarrhea Treatment Covered

Table Global Carcinoid Syndrome

Please fill the form below, to recieve the report sample


+1